Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 added and older maintenance notices (including the v3.4.1 revision and a funding-status notice) removed; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding informing users that updates may not be up to date and providing status of the NIH Clinical Center, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe glossary feature is now visible, and the page includes new metadata entries: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study details content or layout.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer shows a new 'Revision: v3.3.3' label and removes the older 'Revision: v3.3.2' label and the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded a clarifying note that PubMed-listed publications are automatically filled in and may not all pertain to the study, and updated the revision to v3.3.2, while removing the previous language stating that publications come from PubMed and are automatically generated by ClinicalTrials.gov with the NCT number (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.